Regeneron Pharmaceuticals (REGN) Financial Analysis & Valuation | Quarter Chart

Regeneron Pharmaceuticals (REGN)

REGN
Price: $631.81
Fair Value: 🔒
🔒score
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascular... more
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medic... more
Description Shares
Market Cap$65.09BExchangeNASDAQ
SectorHealthcareIndustryBiotechnology
CountryUSCEOLeonard S. Schleifer
IPO Date1991-04-02CAGR0.26%
Employees15,158Websitewww.regeneron.com
Div. Yield1.3%Payout Ratio0.08%
Buy Back Yield13.28%Total Yield14.58%
REGN chart loading...
Fundamentals Technicals
Enterprise Value$79.37BP/E Ratio13.85
Forward P/E11.75PEG Ratio-2.14
P/S Ratio1.91P/B Ratio0.91
P/CF Ratio5.76P/FCF Ratio6.86
EPS$45.63EPS Growth 1Y4.48%
EPS Growth 3Y11.52%EPS Growth 5Y16.16%
Revenue Growth 1Y5.92%Gross Margin0.85%
Operating Margin0.24%Profit Margin0.3%
ROE0.14%ROA0.11%
ROCE0.1%Current Ratio3.57
Quick Ratio2.96Cash Ratio0.58
Debt/Equity0.09Interest Coverage75.61
Altman Z Score6.55Piotroski Score5

View Regeneron Pharmaceuticals financial charts →